Predictors of grade ≥ 2 and grade ≥ 3 radiation pneumonitis in patients with locally advanced non-small cell lung cancer treated with three-dimensional conformal radiotherapy

References

• Wang S, Liao Z, Wei X, Liu H, Tucker S, Hu C, et al. Analysis of clinical and dosimetric factors associated with treatment-related pneumonitis (TRP) in patients with non-small-cell lung cancer (NSCLC) treated with concurrent chemotherapy and three-dimensional conformal radiotherapy (3D-CRT). Int J Radiat Oncol Biol Phys 2006;66:1399–407.
   PubMed Web of Science ®Google Scholar
• Kimura T, Togami T, Takashima H, Nishiyama Y, Ohkawa M, Nagata Y. Radiation pneumonitis in patients with lung and mediastinal tumours: A retrospective study of risk factors focused on pulmonary emphysema. Br J Radiol 2012;85: 135–41.
   PubMed Web of Science ®Google Scholar
• Fay M, Tan A, Fisher R, Mac Manus M, Wirth A, Ball D. Dose-volume histogram analysis as predictor of radiation pneumonitis in primary lung cancer patients treated with radiotherapy. Int J Radiat Oncol Biol Phys 2005;61:1355–63.
   PubMed Web of Science ®Google Scholar
• Barriger RB, Fakiris AJ, Hanna N, Yu M, Mantravadi P, Mcgarry RC. Dose-volume analysis of radiation pneumonitis in non-small-cell lung cancer patients treated with concurrent cisplatinum and etoposide with or without consolidation docetaxel. Int J Radiat Oncol Biol Phys 2010;78:1381–6.
   PubMed Web of Science ®Google Scholar
• Kim TH, Cho KH, Pyo HR, Lee JS, Han JY, Zo JI, et al. Dose-volumetric parameters for predicting severe radiation pneumonitis after three-dimensional conformal radiation therapy for lung cancer. Radiology 2005;235:208–15.
   PubMed Web of Science ®Google Scholar
• Shi A, Zhu G, Wu H, Yu R, Li F, Xu B. Analysis of clinical and dosimetric factors associated with severe acute radiation pneumonitis in patients with locally advanced non-small cell lung cancer treated with concurrent chemotherapy and intensity-modulated radiotherapy. Radiat Oncol 2010;12:35.
   Web of Science ®Google Scholar
• Parashar B, Edward A, Mehta R, Pasmantier M, Wernicke AG, Sabbas A, et al. Chemotherapy significantly increases the risk of radiation pneumonitis in radiation therapy of advanced lung cancer. Am J Clin Oncol 2011;34:160–4.
   PubMed Web of Science ®Google Scholar
• Robnett TJ, Machtay M, Vines EF, McKenna MG, Algazy KM, McKenna WG. Factors predicting severe radiation pneumonitis in patients receiving definitive chemoradiation for lung cancer. Int J Radiat Oncol Biol Phys 2000;48: 89–94.
   PubMed Web of Science ®Google Scholar
• Dang J, Li G, Lu XB, Yao L, Zhang S, Yu Z. Analysis of related factors associated with radiation pneumonitis in patients with locally advanced non-small-cell lung cancer treated with three-dimensional conformal radiotherapy. J Cancer Res Clin Oncol 2010;136:1169–78.
   PubMed Web of Science ®Google Scholar
• Jin H, Tucker SL, Liu HH, Wei X, Yom SS, Wang S, et al. Dose-volume thresholds and smoking status for the risk of treatment-related pneumonitis in inoperable non-small cell lung cancer treated with definitive radiotherapy. Radiother Oncol 2009;91:427–32.
   PubMed Web of Science ®Google Scholar
• Semrau S, Bier A, Thierbach U, Virchow C, Ketterer P, Fietkau R. Concurrent radiochemotherapy with vinorelbine plus cisplatin or carboplatin in patients with locally advanced non-small-cell lung cancer (NSCLC) and an increased risk of treatment complications: Preliminary results. Strahlenther Onkol 2003;179:823–31.
   PubMed Web of Science ®Google Scholar
• Gravs PR, Siddiqui F, Anscher MS, Movsas B. Radiation pulmonary toxicity: From mechanisms to management. Semin Radiat Oncol 2010;20:201–7.
   PubMed Web of Science ®Google Scholar
• Trotti A, Colevas AD, Setser A, Rusch V, Jaques D, Budach V, et al. CTCAE v3.0: Development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol 2003;13:176–81.
   PubMed Web of Science ®Google Scholar
• Wang JB, Cao JZ, Yuan SH, Wei J, Douglas AB, Dai JR, et al. Poor baseline pulmonary function may not increase the risk of radiation-induced lung toxicity. Int J Radiat Oncol Biol Phys Epub 2012 Jul 24.
   Google Scholar
• Onishi H, Kuriyama K, Yamaguchi M, Komiyama T, Tanaka S, Araki T, et al. Concurrent two-dimensional radiotherapy and weekly docetaxel in the treatment of stage III non-small cell lung cancer: A good local response but no good survival due to radiation pneumonitis. Lung Cancer 2003; 40:79–84.
   PubMed Web of Science ®Google Scholar
• Sunyach MP, Falchero L, Pommier P, Perol M, Arpin D, Vincent M, et al. Prospective evaluation of early lung toxicity following three-dimensional conformal radiation therapy in non-small-cell lung cancer: Preliminary results. Int J Radiat Oncol Biol Phys 2000;48:459–63.
   PubMed Web of Science ®Google Scholar
• Huang EX, Hope AJ, Lindsay PE, Trovo M, El Naqa I, Deasy JO, et al. Heart irradiation as a risk factor for radiation pneumonitis. Acta Oncol 2011;50:51–60.
   PubMed Web of Science ®Google Scholar
• Van Luijk P, Faber H, Meertens H, Schippers JM, Langendijk JA. The impact of heart irradiation on dose-volume effects in the rat lung. Int J Radiat Oncol Biol Phys 2007;69: 552–9.
   PubMed Web of Science ®Google Scholar
• Van Luijk P, Novakova-Jiresova A, Faber H, Steneker MN, Kampinga HH, Meertens H, et al. Relation between radiation-induced whole lung functional loss and regional structural changes in partial irradiated rat lung. Int J Radiat Oncol Biol Phys 2006;64:1495–502.
   PubMed Web of Science ®Google Scholar